INTRODUCTION
Differentiated cells are thought to be stably committed to their fate; however, there is evidence to indicate that dedifferentiation events can take place. Urodele amphibians and teleost fish can replace lost anatomical parts by a process of migration, dedifferentiation, proliferation, and redifferentiation of epithelial cells in the wounded area. Functional reprogramming of differentiated cell nuclei has also been illustrated by the derivation of pluripotent embryonic stem (ES) cells (ESCs) (Cibelli et al., 1998; Munsie et al., 2000; Wakayama et al., 2001; Hwang et al., 2004) and by the live birth of cloned animals (Wilmut et al., 2002; Gurdon and Byrne, 2003) after nuclear transplantation into unfertilized eggs. Notably, Xenopus eggs can reprogram mammalian somatic nuclei to express the POU family member homeodomain transcription factor gene Oct4 by a process requiring DNA demethylation (Simonsson and Gurdon, 2004) . DNA demethylation also occurs after fusion of mouse thymocytes with embryonic germ (EG) cells (EGCs) or ESCs (Tada et al., 1997 (Tada et al., , 2001 ; but interestingly, only EG cells are capable of demethylating imprinted genes (Tada et al., 1997) . Similarly, fusion of neuronal progenitor cells (Pells et al., 2002; Ying et al., 2002) or bone marrow-derived cells (Terada et al., 2002) with ESCs results in hybrids that express markers of pluripotency (Pells et al., 2002) , contribute to chimeras (Ying et al., 2002) , and form teratomas (Terada et al., 2002) . Similar observations resulted from fusing human fibroblasts with ESCs (Cowan et al., 2005) . Fusion of embryonal carcinoma (EC) cells (ECCs) with T-lymphoma cells also promotes the formation of colonies expressing pluripotent cell transcripts from the lymphoma genome (Flasza et al., 2003) . Thus, components of pluripotent EG, ES, or EC cells have the potential of eliciting reprogramming events in a somatic genome.
As an alternative to fusion, somatic nuclear function may also be altered using nuclear and cytoplasmic extracts, with the rationale that extracts provide the necessary regulatory components. Notably, extracts of regenerating newt limbs promote cell cycle reentry and down-regulation of myogenic markers in differentiated myotubes (McGann et al., 2001 ). Furthermore, we have shown that kidney epithelial 293T cells permeabilized with streptolysin O (SLO) and briefly exposed to an extract of Jurkat T-cells take on T-cell properties, including growth in aggregates, chromatin remodeling, expression of T-cell-specific genes and surface receptors, secretion of interleukin-2, and stimulation-dependent assembly of the interleukin-2 receptor (Håkelien et al., , 2005 Landsverk et al., 2002) . Similarly, lysates of cardiomyocytes or insulinoma cells elicit expression of cardiomyocyte or ␤-cell markers in adipose stem cells and fibroblasts (Håkelien et al., 2004) , and a pneumocyte extract was recently shown to induce differentiation of ESCs into a pneumocyte phenotype (Qin et al., 2005) . 293T cells were also shown to express pluripotency markers such OCT4 and GCAP and down-regulate a kidney marker after coculture with extract of Xenopus eggs (Hansis et al., 2004) . Despite these observations, evidence for induction of epigenetic reprogramming events in large numbers of cells by extracts is lacking.
Teratocarcinomas are a particular type of germ cell tumors that contain undifferentiated stem cells and differentiated derivatives that can include endoderm, mesoderm, and ectoderm germ layers (Chambers and Smith, 2004) . Undifferentiated carcinoma cells can be cultured to give rise to lines of ECCs. ECCs form malignant teratocarcinomas when transplanted into ectopic sites; however, some ECC lines can also contribute to tissues of the developing fetus when introduced into a blastocyst (Blelloch et al., 2004) . Undifferentiated human teratocarcinoma NCCIT cells were established from a mediastinal mixed germ cell tumor (Teshima et al., 1988) . NCCIT is at a stage intermediate between a seminoma (a precursor of germ cell tumors) and an embryonal carcinoma (Damjanov et al., 1993) . NCCIT is a developmentally pluripotent cell line that can differentiate into derivatives of all three embryonic germ layers and extraembryonic cell lineages (Damjanov et al., 1993) .
This study tests the hypothesis that an extract of undifferentiated somatic cells can elicit dedifferentiation in a somatic cell line. Based on morphological and immunolabeling observations, gene expression profiling, DNA methylation assays, and functional assessments, we show that 293T and NIH3T3 cells can be programmed by extracts of undifferentiated NCCIT cells or mouse ES cells to acquire characteristics of pluripotency.
MATERIALS AND METHODS

Cells
NCCIT, Jurkat (clone E6-1), and 293T cells (American Type Culture Collection, Vanassas, MD) were cultured in RPMI 1640 medium (Sigma-Aldrich, St. Louis, MO) with 10% fetal calf serum (FCS), 2 mM l-glutamine, 1 mM sodium pyruvate, and nonessential amino acids (complete RPMI 1640 medium). NIH3T3 Swiss-Albino fibroblasts (American Type Culture Collection) were cultured in DMEM (Sigma-Aldrich) with 10% FCS, l-glutamine, and 0.1 mM ␤-mercaptoethanol. Mouse ESCs were isolated from inner cell masses of strain sv129 blastocysts and plated on mouse fibroblast ␥-irradiated feeder layers in ESC medium (DMEM, 15% FCS, 0.1 mM ␤-mercaptoethanol, nonessential amino acids, and 1% penicillin/streptomycin) supplemented with 1000 U/ml (10 ng/ml) recombinant leukemia inhibitory factor (LIF; SigmaAldrich) on gelatin-coated plates. Before harvesting for preparing extracts, ESCs were passaged and cultured under feeder-free conditions in RPMI 1640 medium containing 10 ng/ml LIF. Cells treated with NCCIT or 293T extract were seeded at 100,000 cells per well in a 48-well plate and cultured in 250 l of complete RMPI 1640 medium with antibiotics. Cells exposed to ESC extract were cultured as ESCs with 10 ng/ml LIF under feeder-free conditions.
Cell Extracts
To prepare NCCIT extracts, cells were washed in phosphate-buffered saline (PBS) and in cell lysis buffer (100 mM HEPES, pH 8.2, 50 mM NaCl, 5 mM MgCl 2 , 1 mM dithiothreitol, and protease inhibitors), sedimented at 400 ϫ g, resuspended in 1 volume of cold cell lysis buffer, and incubated for 30 -45 min on ice. Cells were sonicated on ice in 200-l aliquots using a Labsonic-M pulse sonicator fitted with a 3-mm-diameter probe (B. Braun Biotech, Melsungen, Germany) until all cells and nuclei were lysed, as judged by microscopy (our unpublished data). The lysate was sedimented at 15,000 ϫ g for 15 min at 4°C to pellet the coarse material. The supernatant was aliquoted, frozen in liquid nitrogen, and stored for up to 9 mo at Ϫ80°C. Lysate of 95,583 Ϯ 10,966 NCCIT cells was used to generate 1 l of extract. Protein concentration of the NCCIT extract was 29.5 Ϯ 4.6 mg/ml (Bradford) and pH was 7.0 Ϯ 0.0 (4 batches). ESC extracts (25-30 mg/ml protein) were similarly prepared from LIF-adapted ESC cultures. 293T, Jurkat, and NIH3T3 extracts were also prepared as described above. If necessary, extracts were diluted with H 2 O before use to adjust osmolarity to ϳ300 mOsM.
SLO-mediated Permeabilization and Cell Extract Treatment
293T and 3T3 cells were washed in cold PBS and in cold Ca 2ϩ -and Mg 2ϩ -free Hank's balanced salt solution (HBSS) (Invitrogen, Carlsbad, CA). Cells were resuspended in aliquots of 100,000 cells/100 l of HBSS, or multiples thereof; placed in 1.5-ml tubes; and centrifuged at 120 ϫ g for 5 min at 4°C in a swing-out rotor. Sedimented cells were suspended in 97.7 l of cold HBSS, tubes were placed in a H 2 O bath at 37°C for 2 min, and 2.3 l of SLO (Sigma-Aldrich) (100 g/ml stock diluted 1:10 in cold HBSS) was added to a final SLO concentration of 230 ng/ml. Samples were incubated horizontally in a H 2 O bath for 50 min at 37°C with occasional agitation and set on ice. Samples were diluted with 200 l of cold HBSS, and cells were sedimented at 120 ϫ g for 5 min at 4°C. Permeabilization was assessed by monitoring uptake of a 70,000-M r Texas Red-conjugated dextran (50 g/ml; Invitrogen) in a separate sample 24 h after resealing and replating the cells (our unpublished data). Permeabilization efficiency under these conditions was ϳ80%.
After permeabilization, cells were suspended at 1000 cells/l in 100 l of NCCIT, ESC or indicated control extract (or multiples thereof) containing an ATP-regenerating system (1 mM ATP, 10 mM creatine phosphate, and 25 g/ml creatine kinase; Sigma-Aldrich), 100 M GTP (Sigma-Aldrich), and 1 mM each nucleotide triphosphate (NTP; Roche Diagnostics, Mannheim, Germany). The tube containing cells was incubated horizontally for 1 h at 37°C in a H 2 O bath with occasional agitation. To reseal plasma membranes, the extract was diluted with complete RPMI 1640 medium containing 2 mM CaCl 2 and antibiotics, and cells were seeded at 100,000 cells per well on a 48-well plate. After 2 h, floating cells were removed, and plated cells were cultured in complete RPMI 1640 medium.
GTGATATGGCTG-3Ј, which cover nucleotides 39 -265 of GenBank locus AF168998. PCR conditions were 95°C for 3 min and 30 cycles of 95°C for 45 s, 60°C for 45 s, and 72°C for 45 s followed by 10 min at 72°C. PCR products were visualized by ethidium bromide staining in a 2% agarose gel.
Reverse transcription (RT)-PCR reactions were carried from 200 to 1000 ng of total RNA using the Iscript cDNA synthesis kit (Bio-Rad, Hercules, CA). Quantitative RT-PCR reactions were performed in triplicates on a MyiQ real-time PCR detection system using either IQ SYBR Green (Bio-Rad) or ProbeLibrary probes (Exiqon, Vedbaek, Denmark) as indicated in Table S1 . SYBR Green PCR conditions were 95°C for 4.5 min and 40 cycles of 95°C for 30 s, 60°C for 30 s, and 72°C for 30 s, using GAPDH as normalization control. ProbeLibrary PCR conditions were 95°C for 7 min and 40 cycles of 94°C for 20 s and 60°C for 1 min using ACTB as standard.
Bisulfite Sequencing
DNA was purified by phenol-chloroform-isoamylalcohol extraction or by using the GenElute mammalian genomic DNA miniprep kit (Sigma-Aldrich). Bisulfite conversion was performed using the MethylEasy DNA bisulphite modification kit (Human Genetic Signatures, Sydney, Australia) as described by the manufacturer. Converted DNA was amplified by seminested PCR using primers (Human Genetic Signatures) specific for the human OCT4, LMNA, and LMNB1 genes (see Results), and PCR products were sequenced. PCR conditions were, for each of the nested PCRs, 95°C for 3 min and 30 cycles of 95°C for 1 min, 50°C for 2 min, and 72°C for 2 min, followed by 10 min at 72°C.
Induction of Neuronal Differentiation
To generate neuronal derivatives (Stewart et al., 2003) , cells were seeded in complete RPMI 1640 medium at 5 ϫ 10 5 cells per 90-mm sterile bacterial culture dish. Suspension cultures were maintained for 24 h before adding 10 M all-trans-retinoic acid (Sigma-Aldrich). Cells were cultured for 3-5 wk in retinoic acid, replacing the medium every 2-3 d. Subsequently, cell aggregates were washed in complete RPMI 1640 medium and plated onto poly-l-lysine (10 g/ml; Sigma-Aldrich)-coated plates in complete RPMI 1640 medium containing the mitotic inhibitors fluorodeoxyuridine (10 M; Sigma-Aldrich), cytosine arabinosine (1 M; Sigma-Aldrich), and uridine (10 M; SigmaAldrich).
Mesodermal Lineage Differentiation
Cells were cultured for 21 d in complete RPMI 1640 medium containing 10 M all-trans-retinoic acid and washed in complete RPMI 1640 medium. For adipogenic differentiation, cells were cultured for a further 21 d in DMEM/ Ham's F-12 supplemented with 10% FCS, dexamethasone, insulin, and indomethacin (Boquest et al., 2005) . Cells were fixed with 4% formalin, washed in 5% isopropanol, and stained for 15 min with Oil-Red-O (Sigma-Aldrich). For osteogenic differentiation, cells were cultured for 21 d in DMEM containing 10% FCS, dexamethasone, ␤-glycerophosphate, and l-ascorbate-2-phosphate (Boquest et al., 2005) . Extracellular matrix mineralization nodules were visualized by Alzarin red staining. Endothelial differentiation was performed as described previously (Planat-Benard et al., 2004) . Briefly, NCCIT extracttreated cells and controls were harvested by flask shaking and plated at 2 ϫ 10 5 cells per milliliter in 3 ml of methylcellulose (Methocult GF H4434; Stem Cell Technologies, Vancouver, British Columbia, Canada) and cultured for 7 d.
Immunological Procedures
For immunofluorescence, cells were seeded onto coverslips, fixed with 3% paraformaldehyde, permeabilized with 0.1% Triton X-100, blocked with bovine serum albumin, and hybridized with relevant antibodies. Antibodies used were a rabbit polyclonal anti-Oct4 (1:1000 dilution; Santa Cruz Biotechnology, Santa Cruz, CA), an anti-lamin A/C monoclonal antibody (mAb) (1:50 dilution; mAb XB10; BAbCO, Covance Research Products, Grand Rapids, MI), and a rabbit polyclonal antibody against a peptide of human B-type lamins (1:1000) (Chaudhary and Courvalin, 1993) . Rabbit polyclonal antibodies (1:200) against neurofilament NF200 were from Sigma-Aldrich, and antiNeuN (mAb377) and anti-nestin antibodies (mAb5362; 1:200) were from Chemicon International (Temecula, CA). Secondary antibodies were Cy2-and Cy3-conjugated anti-mouse and anti-rabbit antibodies and Cy3-conjugated anti-rabbit antibodies (1:1000 dilution; Jackson ImmunoResearch Laboratories, West Grove, PA). For direct immunolabeling, cells (ϳ300,000) were incubated with fluorescein isothiocyanate-conjugated mouse anti-human CD31 or rabbit anti-human CD144 antibodies (1:10 dilution; Serotec, Oxford, United Kingdom) in 100 l of PBS. After extensive washing in PBS, cells were fixed with 3% paraformaldehyde before viewing. For Western blotting, antibodies used were anti-Oct4 (1:250), anti-lamin A/C (1:500), anti-lamin B (1:5000), and anti-tubulin (1:250; Santa Cruz Biotechnology). Immunodepletion of Oct4 from mouse ESC extract was performed using anti-Oct4 antibodies (1:50 dilution) bound to protein A/G-Sepharose beads. After 1-h incubation in extract at 4°C, bead complexes were removed by sedimentation at 4000 ϫ g for 5 min, and a second round of immunoprecipitation was carried out for 30 min at 4°C. After sedimentation of the beads, an aliquot of the supernatant was removed for Western blotting, whereas the extract was used for cell treatment.
Alkaline Phosphatase Assay
Relative intracellular ALP levels were determined using a dot-blot assay. Two microliters of soluble lysate (15,000 ϫ g supernatant at 20 g/l protein) from indicated cell types were spotted on a dry 45-m nitrocellulose membrane (Bio-Rad). The membrane was wetted in 50 mM NaCl, 10 mM Tris-HCl, pH 7.0, and ALP was revealed by applying an Alk-Phos Direct detection solution (GE Healthcare, Piscataway, NJ). Light emission on film was quantified by densitometry within a linear signal range.
RESULTS
Treatment of 293T Cells with NCCIT Extract Promotes Colony Formation
293T cells were permeabilized with SLO and exposed for 1 h to an extract of undifferentiated NCCIT cells. In vitro culture of extract-treated cells was accompanied by morphological, immunological, gene expression, and functional analyses over 8 -12 wk to evaluate induction of dedifferentiation in two to six independent experiments. As controls, permeabilized 293T cells were treated with extract of 293T or Jurkat T-cells.
A first result of NCCIT extract exposure was a change in morphology of 293T cells. Within 2 wk, colonies with defined edges developed and resembled NCCIT colonies (Figure 1A and B, . This phenotype was maintained for at least 12 wk in culture, corresponding to Ͼ50 population doublings and 23 passages ( Figure 1B , a-e). The phenotype was not a mere consequence of treatment with any extract as 293T cells incubated in their own extract did not form colonies ( Figure 1B , f-j), and 293T cells treated with an extract of Jurkat cells formed clearly morphologically distinct aggregates ( Figure 1C ). The latter were reminiscent of Jurkat T-cell clusters (Håkelien et al., 2005) .
The NCCIT Extract Elicits Expression of Oct4 and Oct4-responsive Genes, Expression of ESC Markers, and Repression of A-Type Lamins
Expression of the homeodomain protein Oct4, a POU family transcription factor, is restricted to germ cells, preimplantation embryos, the epiblast of early postimplantation embryos and ESCs (Chambers and Smith, 2004) . As expected, Oct4 was detected in the nucleus of NCCIT but not 293T cells (Figure 2A ), and identity of the protein was confirmed by immunoblotting (our unpublished data). One week after treatment with NCCIT extract, Ͼ60% of 293T cells displayed intranuclear Oct4, whereas Oct4 remained undetectable in 293T extract-treated cells (Figure 2 , B and C).
We next monitored the loss A-type nuclear lamins, a marker of differentiated cells (Hutchison and Worman, 2004) , from 293T cells. mAbs against lamins A and C (lamin A/C) decorated the nuclear periphery of 293T but not NCCIT cells (Figure 2A ). In contrast, 1 wk after NCCIT extract treatment, lamin A/C was undetectable in Ͼ60% of the cells, whereas controls displayed lamin A/C labeling ( Figure 2 , B and C). Notably, Oct4 expression paralleled the loss of lamin A/C expression in the same cells ( Figure 2C ), suggesting that these cells were undergoing dedifferentiation. Expression of the ubiquitously expressed B-type lamins (Hutchison and Worman, 2004 ) remained unaltered ( Figure  2 , A-C).
Induction of OCT4 (POU5F1) transcription and loss of LMNA (lamin A) gene expression over time were demonstrated by quantitative RT-PCR analysis 4 wk after extract treatment (Table 1) . Several target genes of Oct4 were also up-regulated, including UTF1, OXT2, REX1, and NANOG. Interestingly, Oct4 is known to act in cooperation with Sox2 (Avilion et al., 2003) , which was also found to be induced in extract-treated cells. Additional markers of pluripotentiality (Hoffman and Carpenter, 2005) up-regulated in NCCIT extract-treated cells and verified by quantitative RT-PCR included ALP 1 (APL), STELLA, AC133, CD9, DMNT3B, and DNMT3L (Table 1) . Expression of these genes was examined and confirmed at 2, 4, and 6 wk after extract treatment but not examined thereafter (our unpublished data). However, genes such as PDGF␣R, FGF2, LEFTY1, LEFTY2, CD135, or CD117 were not expressed in any cell type or were not altered by extract treatment (our unpublished data). As expected, transcripts for the ubiquitously expressed lamin B1 (LMNB1) were not altered by exposure to either extract (Table 1) , supporting our immunofluorescence observations. None of the pluripotency marker transcripts examined by real time RT-PCR were elicited in 293T cells treated with their own extract (our unpublished data). To verify that expression of Oct4 and reduction of A-type lamin expression did take place in 293T cells, 293T cells stably expressing an enhanced green fluorescent protein (EGFP) and a geneticin-resistance gene (293T-EGFP-Gen R cells) were treated with NCCIT extract. After 2 wk of culture with 700 g/ml geneticin, which kills NCCIT cells (our unpublished data), the majority of 293T-EGFP-Gen R cells stained positive for Oct4 ( Figure 3A) . Strong up-regulation of OCT4, SOX2, and APL and moderate up-regulation of STELLA (ϳ2-fold) gene expression were also detected in these cells, whereas LMNA was repressed ( Figure 3B ). We also took advantage of the large T antigen marker carried by 293T cells. PCR analysis indicated that 293T-EGFP-Gen R cells, but not NCCIT cells, contained the SV40 large T antigen transgene ( Figure 3C ), confirming that cells expressing Oct4 were of 293T origin. Of note, karyotyping analysis of 293T cells before and after extract treatment was inconclusive due to the severe aneuploidy and genomic instability of untreated 293T cells (our unpublished data). 293T cell aneuploidy was expected to occur as a result of large T antigen transformation, which is known to cause endoreplication (Wu et al., 2004) .
Last, treatment of NCCIT extract with 500 g/ml DNAse I, which eliminates most detectable DNA in the extract (our unpublished data), before incubating 293T-EGFP-Gen R cells did not affect induction of OCT4, SOX2, APL, and STELLA expression or LMNA repression ( Figure 3B ; ϩDNAse). This argues that Oct4 expression in 293T cells did not emanate from intact DNA derived from the NCCIT extract.
The NCCIT Extract Promotes OCT4 DNA Demethylation
Transfer of mammalian cells into the germinal vesicle of Xenopus oocytes elicits DNA demethylation in the OCT4 promoter, a prerequisite for OCT4 expression in this system (Simonsson and Gurdon, 2004) . The OCT4 region analyzed in our study was from nucleotide 1433-1671 (GenBank sequence AJ297527), encompassing eight potentially methylated cytosines in CpG dinucleotides between conserved regions CR2 and CR3 in the OCT4 promoter (Nordhoff et al., 2001 ) ( Figure 4A ). Bisulfite sequencing showed that this region was unmethylated in NCCIT but methylated in 293T cells ( Figure 4A ). In 293T cells exposed to their own extract, OCT4 remained methylated. However, in NCCIT extracttreated cells, OCT4 demethylation was evident after 4 and 9 wk of culture ( Figure 4A ) and provided molecular support for long-term transcriptional activation of OCT4. Two CpGs showed apparent partial demethylation ( Figure 4A ), which was interpreted as the expected presence of a mixed cell population in which cytosines Ϫ1686 and Ϫ1676 did not undergo demethylation. We concluded therefore that the NCCIT extract was capable of eliciting OCT4 demethylation in 293T cells. OCT4 demethylation was specific for the NCCIT extract and it did not occur in 293T extract ( Figure 4A ).
We also examined the DNA methylation status of LMNA, whose expression is virtually repressed in NCCIT extracttreated cells. The LMNA region analyzed spanned nucleo- tides 2379 -2648 (GenBank L12399), encompassing 34 potentially methylated cytosines found in CpG dinucleotides flanking the ATG translation start ( Figure 4B ). This region is unmethylated in 293T cells and clearly remained unmethylated in NCCIT extract-treated cells ( Figure 4B ). However, we also found an absence of LMNA DNA methylation in this region in NCCIT cells despite the repression of LMNA in these cells ( Figure 4B ). Thus, we concluded that NCCIT extract-treated cells did not undergo aberrant DNA methylation in this region. We cannot ascertain, however, that other regions in the LMNA locus were modified by extract treatment. Last, LMNB1 remained unmethylated regardless of extract treatment ( Figure 4C ), in agreement with its ubiquitous expression. The LMNB1 region examined spanned nucleotides 1594 -1828 (GenBank L37737), encompassing 35 potentially methylated cytosine nucleotides in a CpG island around the ATG start. GAPDH, also ubiquitously expressed and used as reference in our quantitative RT-PCR analyses, also remained largely unmethylated in any cell type examined (our unpublished data).
Transcriptional Profiling of NCCIT Cells Relative to 293T Cells
To evaluate the extent of transcriptional alterations elicited by the NCCIT extract, an Affymetrix U133A GeneChip microarray analysis of 293T cell gene expression was carried out for 8 wk after extract treatment. We took advantage of a SMART PCRcDNA approach that combines PCR amplification and T7 RNA polymerase to amplify submicrogram RNA samples (Ji et al., 2004) . Although some distortion of within-sample stoichiometry occurs with this method, one can assume the same distortion between samples, thus maintenance of between-sample stoichiometry allows comparative analyses.
We first assessed genes significantly (p Ͻ 0.001) up-or down-regulated at a more than threefold difference level in NCCIT compared with 293T cells. A total of 2950 genes were up-regulated, whereas 2528 genes were down-regulated in NCCIT cells, in two independent analyses performed in duplicate. Distributions of up-and down-regulated genes into functional classes were similar, with most genes encoding elements involved in transcription regulation (22 and 19%, respectively) , cytoskeletal organization (6 and 3%), metabolism (4 and 10%), protein synthesis and processing (6 and 4%), cell signaling (10 and 8%), and chromatin organization (6 and 4%) ( Figure S1 ).
NCCIT Extract Induces Expression of NCCIT-specific Genes and Down-Regulation of 293T Genes
The NCCIT extract elicited up-and down-regulation of ϳ1700 -2000 and ϳ1650 -1800 genes, respectively, on any given week relative to 293T cells ( Figure 5B , green and red bars). Of these, ϳ70 and ϳ34%, respectively, were shared with NCCIT cells and qualified as "NCCIT genes" (Figure 5 , A and B, yellow bars; E). Furthermore, the likelihood that expression of these genes was altered by chance rather than as a result of extract treatment was extremely low (p Ͻ 10 Ϫ5 and p Ͻ 10 Ϫ4 , respectively; t tests), indicating that changes were elicited by the NCCIT extract.
We then addressed the specificity of gene expression changes elicited by NCCIT extract. First, exposure of 293T cells to their own extract induced up-or down-regulation of ϳ1600 and ϳ600 genes, respectively ( Figure 5C , green and red bars), of which only ϳ6% were identified as NCCIT genes ( Figure 5C , yellow bars; E; listed in Table S2 ). Similarly, treatment of 293T cells with Jurkat T-cell extract altered expression of a negligible proportion of NCCIT genes ( Figure 5, D and E) . Furthermore, nearly all NCCIT genes affected by 293T or Jurkat extract were the same (Table S2; annotations a,b ), and probabilities that these genes were altered by chance rather than by extract treatment were relatively high (p Ͼ 0.07 and p Ͼ 0.08, respectively; t tests). Resulting numbers of NCCIT genes specifically up-or down-regulated by NCCIT extract and reproducibly in both experiments are shown in Figure 5F (green and red bars, respectively). Thus, the NCCIT extract elicits specific alterations in the 293T cell expression profile. Genes not differentially expressed in NCCIT compared with 293T also seem to be affected.
The consistency of NCCIT gene expression changes in NCCIT extract-treated cells over time was subsequently assessed. Figure 5G (gray bars) shows that 686 genes were consistently up-regulated from weeks 1-8, whereas 161 genes were consistently down-regulated (these genes were shared between both experiments). These genes are listed in Table S3 . The remaining affected genes included those with an onset of up-or down-regulation later than week 1, or those with a more fluctuating expression level. For example, a large number of genes were up-regulated from week 2 onward, and thus they were not taken into account in the above-mentioned analysis. Functional class distribution of the consistently up-or down-regulated genes ( Figure 5H) shows that most annotated up-regulated genes encoded elements involved in transcription, cytoskeletal organization, metabolism, signaling, and chromatin remodeling, whereas down-regulated genes were more evenly distributed across functional classes. Table 2 lists markers of pluripotency represented in the array and that were up-regulated in extract-treated cells. In agreement with our immunolabeling and DNA methylation data, OCT4 (POU5F1) was up-regulated from week 2 onward. Notably, the Oct4-responsive genes UTF1 and REX1/ DRN3 (Hosler et al., 1989; Okuda et al., 1998) were also up-regulated together with SOX2, suggesting the induction Numbers of upand down-regulated NCCIT genes in cells exposed to NCCIT extract are shown in green and red. Gray bars represent genes consistently up-or down-regulated at weeks 1 and 2 (gray bars at week 2), weeks 1, 2, and 4 (gray bars at week 4), etc., and shared between the two experiments. (H) Functional class distribution of genes consistently up-or down-regulated over 8 wk in two experiments (gray bars in G). These genes are listed in Table S3 .
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Vol. 16, December 2005 of Oct4-dependent functions in reprogrammed cells. Telomerase (TERT) and telomerase-associated factor 1 (TERF1) were also increasingly up-regulated. Other pluripotency markers up-regulated were the CD44 stem cell antigen, placental ALP (APL1), LIF, stem cell growth factor ␤ (SCGF), germ cell nuclear factor (GCNF), and integrin ␣6 (INTA6), a putative marker of "stemness" shared between three gene expression profile analyses of mouse ESCs (Fortunel et al., 2003) . Remarkably, except for Dikkopf2 (DKK2), none of the stem cell marker genes listed in Table 2 was affected by treatment with 293T or Jurkat extract, illustrating the extract specificity of changes elicited (Table S4 ). In parallel, LMNA was essentially repressed, whereas expression of B-type lamins (LMNB1 and LMNB2) persisted, consistent with our RT-PCR and immunolabeling data. The kidney-derived 293T cell marker natriuretic peptide receptor C (NPR3) was also strongly down-regulated (Hansis et al., 2004) . We also noted the up-regulation of markers of lineagespecific differentiation to levels comparable with NCCIT expression levels. These included markers of osteogenic, endothelial, myogenic, neurogenic, adipogenic, and chondrogenic lineages (Boquest et al., 2005) . Expression of markers of chondrogenic (DSPG3), neuronal (NRG1, NTS, and MBP), endothelial (VWF), and adipocyte (APOA2) lineages was confirmed by real-time RT-PCR ( Figure 6 ). Furthermore, expression of several housekeeping genes, including 18S, 28S, GAPDH, HPRT1, and ACTB and 35 genes for ribosomal proteins, was unaffected in extract-treated cells (Table S5) . Collectively, these results indicate that the NCCIT extract promotes the up-regulation of markers of pluripotency typically expressed in ECCs or ESCs and suggest, in addition, the establishment of a "multilineage priming" in 293T cells treated with NCCIT extract.
Oncogenes and Tumor Suppressor Genes Are Not Affected by NCCIT Extract Treatment
NCCIT is a tumor cell line that bears genetic mutations required for its expansion and phenotypic characteristics. We determined whether mRNA levels for oncogenes and tumor suppressor genes were altered in 293T cells exposed to NCCIT extract, relative to untreated cells. We did not observe any up-regulation or induction of oncogene expression in NCCIT extract-treated cells. Genes such c-MYC, c-MYC-responsive genes, genes encoding Myc-interacting or Myc-regulated proteins, and genes encoding RAB and RAF isoforms were not significantly expressed in any of the cell types examined nor were they altered by NCCIT extract. Among tumor suppressor genes, P53 was strongly up-regulated in NCCIT compared with 293T (p Ͻ 10 Ϫ4 ) but remained unaltered in NCCIT extract-treated cells (p Ͼ 0.05). Other tumor suppressor genes, however, were either not significantly expressed in 293T or NCCIT [RB1, TSC1, TSC22, BRCA1, BRCA2, CDKN2A (p16) , CDKN1A (p21, Cip1), CDKN1C (P57, Kip2), MSH2, STK11, MEN1, and MEN2] or were expressed at similar levels in both cell types (PTCH, PTEN, and WT1D) . These genes remained unaltered by treatment with NCCIT extract (p Ͼ 0.05). Similarly, genes encoding enzymes involved in DNA repair (XPA, ERCC5, FANCA, -C, -E, -F, and -G) were not significantly expressed in either cell types nor altered by extract treatment. ATM was highly expressed in 293T and NCCIT cells and remained unchanged in extract-treated cells. Because it is unlikely that NCCIT genetic lesions are passed onto the 293T cell genome through extract treatment, acquisition of an NCCIT phenotype by 293T cells implies that either the phenotype obtained is independent of NCCIT lesions or that genetic mutations that gave rise to the NCCIT tumor phenotype are dispensable for the maintenance of this state.
Retinoic Acid Stimulation of NCCIT Extract-treated Cells Induces Neuronal Differentiation
To determine whether NCCIT extract-treated 293T cells acquired a potential for pluripotency, we attempted to induce neuronal differentiation in vitro with retinoic acid (Stewart et al., 2003) . 293T, NCCIT (our unpublished data), and extracttreated cells were exposed to 10 M all-trans-retinoic acid and were maintained as suspended aggregation cultures ( Figure 7A) . Suspensions of all cell types formed disorganized aggregates in bacteriological dishes but after 2 wk in retinoic acid, the cells formed spheres that sometimes fused with one another ( Figure 7A ). This was particularly evident for NCCIT extract-treated 293T cells ( Figure 7A, top) . After washing and replating, cells adhered to poly-l-lysine-coated coverslips. However, only NCCIT and NCCIT extracttreated cells showed evidence of neurite outgrowth already after culture for 2 d in the absence of retinoic acid but in the presence of mitotic inhibitors ( Figure 7A , bottom, and S2A). This suggested that neuronal progenitor cells emanated from NCCIT extract-treated 293T cells.
Immmunolabeling and real-time RT-PCR analyses confirmed the induction of a neuronal phenotype. Spheres of NCCIT cells and of NCCIT extract-treated cells showed a reduction of Oct4 protein to a level nearly undetectable by immunofluorescence in Ͼ90% of the cells ( Figure 7B ). This was confirmed by a threefold reduction of OCT4 transcript levels in these cells compared with cells not stimulated with retinoic acid ( Figure 7C ). Moreover, expression of the intermediate filament nestin (NES), a marker of neuronal precursor cells (Cattaneo and McKay, 1990) , was induced at the transcriptional and translational levels by retinoic acid in NCCIT extract-treated but not 293T extract-treated, cells (Figure 7 , B and C). Furthermore, LMNA, repressed after exposure to NCCIT extract (Figure 2 and Table 1 ) was strongly up-regulated de novo by retinoic acid but only in NCCIT extract-treated cells ( Figure 7C ). This indicated that the cells redifferentiated upon retinoic acid exposure. Last, the majority of NCCIT extract-treated cells, as NCCIT cells ( Figure S2B and S2C) were positive for the neuronal markers NeuN and NF200 ( Figure 7D ). We concluded that NCCIT extract-treated 293T cells can be induced to differentiate into a neuronal phenotype in vitro. 
NCCIT Extract Enhances Differentiation Potential toward Adipogenic, Osteogenic, and Endothelial Lineages
To provide additional evidence for induction of differentiation potential in 293T cells treated with NCCIT extract, we determined whether the cells would acquire phenotypic characteristics of adipocytes and osteoblasts. After 3 wk of retinoic acid treatment and 3 wk of stimulation in appropriate differentiation medium (see Materials and Methods), a proportion of 293T cells, NCCIT cells, and of cells treated with 293T or NCCIT extract were induced to differentiate toward adipogenic and osteogenic pathways (Figures 8, A and B, and S2D and S2E). Intracellular lipid staining with Oil-Red-O showed enhanced differentiation of NCCIT extract-treated cells relative to any other cell type toward the adipogenic pathway ( Figure 8A ). Moreover, significantly more Alzarin red-stained mineralized nodules were detected in NCCIT extract-treated 293T cells compared with any other cell type (Figure 8B , arrows; p Ͻ 10 Ϫ6 ; t tests).
Additionally, induction of endothelial differentiation of NCCIT extract-treated cells in methylcellulose triggered the appearance of an endothelial cell phenotype after 7 d. With cells forming elongated "tracks" in methylcellulose ( Figure  8C ; see controls in Figure S2F ). Morphological changes were supported by immunoreactivity to CD31 and CD144, two endothelial cell surface markers (Boquest et al., 2005) ( Figure  8D ), and by induction of expression of CD31 (2 Ϯ 0.15-fold up-regulation compared with undifferentiated, extracttreated cells) and CD144 (347 Ϯ 97.6-fold up-regulation). Collectively, these results indicate that treatment with NCCIT extract enhances the ability of 293T cells to differentiate into ectoderm and several mesoderm lineages.
A Mouse ES Cell Extract Promotes A-Type Lamin DownRegulation and Oct4 Transcription in NIH3T3 Fibroblasts
A nuclear and cytoplasmic extract of mouse ESCs was prepared to determine whether it was capable of eliciting mark- ers of pluripotency, as with the NCCIT extract. Within 4 -9 d after ESC extract treatment, a proportion 3T3 cells formed distinct colonies of small round cells that lifted from the surface to form embryoid-like bodies ( Figure 9A ). Fifty to 100 embryoid-like bodies were identified in 100-mm culture plates, whereas most remaining cells retained a fibroblast morphology. Smaller aggregates of round (nonmitotic) cells were also detected. In contrast, 3T3 cells exposed to their own extract grew as fibroblasts and were not distinguishable from untreated cells ( Figure 9A ). The ESC-like phenotype was maintained after passaging cells weekly for at least 10 wk. RT-PCR analysis of the embryoid body-like structures clearly revealed Oct4 transcripts (see below), whereas Lmna, but not Lmnb1, was strongly down-regulated ( Figure 9B ). Embryoid-like bodies derived from ESC extract-treated cells expressed ALP, another embryonic and ESC marker, after 8 d of culture (Figure 9 , C and D; 1 wk after extract exposure). ALP expression was inhibited by a 24-h exposure to 25 M RNA PolII inhibitor 5,6-dichloro-1-d-ribofuranosyl benzimidazole (DRB) or to 10 g/ml protein synthesis inhibitor cycloheximide (CHX) ( Figure 9D ). Thus, ALP expression was endogenous to the extract-treated cells. No expression was detected in control cells (Figure 9, C and D) . Furthermore, immunofluorescence analysis showed that ϳ90% of embryoid-like body-derived cells expressed intranuclear Oct-4, whereas in the same cells lamin A/C expression was reduced to undetectable levels (our unpublished data). Immunoblots confirmed this observation ( Figure 9E ) and indicated that ESC extract-treated cells expressed Oct4 to levels similar to ESCs. Oct4 not was detected in 3T3 cells incubated in their own extract or in intact (nonpermeabilized) 3T3 cells treated with ESC extract ( Figure  9E ). This ruled out the detection of an unspecific anti-Oct4 immunoreactive product and of any extract-derived Oct4 protein that would stick to the cell surface. Detection of Oct4 protein in ESC extract-treated cells required a threshold Closer examination of the need for exogenous nucleotides to promote Oct4 detection indicated a requirement for ATP and GTP hydrolysis ( Figure 9G ). Indeed, ATP depletion from the extract with glucose and hexokinase, replacement of exogenous ATP with adenosine-5Ј-O-(3-thio)triphosphate or adenyl-5Ј-yl imidodiphosphate, or GTP removal or substitution with guanosine 5Ј-O-(3-thio)triphosphate or guanosine 5Ј-[␤,␥-imido]triphosphate abrogated Oct4 detection ( Figure 9G ). This is consistent with a role of active nuclear import for transcription in cell extracts . Furthermore, heat treatment (95°C; 5 min), trypsinization, or proteinase K treatment of the ESC extract abolished Oct4 detection in 3T3 cells (Figure 10 ). However, DNAse I (100 mg/ml) or RNAse A (50 mg/ml) did not affect Oct4 levels in extract-treated cells (see below; Figure 10 ), ruling out a significant contribution of mRNA or DNA of extract origin.
The ESC Extract Induces a Biphasic Wave of Oct4 Transcription and Translation
To gain insight on the dynamics of Oct4 induction in ESC extract-treated cells and evaluate any putative contribution of extract-derived Oct4 protein, we assessed intracellular Oct4 protein levels over time after extract treatment and determined the effect of PolII and protein synthesis inhibitors on Oct4 induction. Relative Oct4 levels in ESC extracttreated cells are shown in Figure 11A . A biphasic response to extract exposure was observed. First, Oct4 was detected as early as 1 h after recovery of the cells from the extract, and the level peaked at 24 h ( Figure 11A ). This peak was followed by a marked reduction of Oct4 by 36 h to a level barely detectable by 48 h. By 72 h, however, a second wave of Oct4 was detected of amplitude similar to or higher than the first wave, and it persisted for at least 5 d ( Figure 11A ). Oct4 protein was also detected in these cells 5 and 10 wk after extract treatment (our unpublished data); thus, we anticipate that the second elevation of Oct4 in these cells is long-lasting. Of note, the biphasic Oct4 protein elevation paralleled fluctuations in Oct4 transcripts, as determined by real-time RT-.PCR ( Figure 11D ), suggesting a short half-life (a few hours) of Oct4 RNA and protein.
Culture of ESC extract-treated cells with 25 M DRB from 1 to 24 h after extract treatment dramatically reduced Oct4 levels by 1 h ( Figure 11B, top) , suggesting that Oct4 detection at this time point resulted primarily from transcription but also to a minor extent from uptake of Oct4 protein from the extract. This hypothesis was verified by a complete double immunodepletion of Oct4 from the ESC extract ( Figure 12A ), which resulted in a reduced Oct4 level by 1 h in non-DRB-treated 3T3 cells, without affecting subsequent levels ( Figure 12, B and 1C) . DRB exposure of cells treated with Oct4-depleted extract completely abolished Oct4 detection by 1 h (our unpublished data). We concluded, therefore, that Oct4 detected by the first hour of culture after extract exposure originated from the extract and from RNA PolII-mediated transcription and translation.
The effect of PolII inhibition on the dynamics of Oct4 expression in ESC extract-treated cells differed with timing of drug exposure after extract treatment. A 1-to 24-h DRB treatment almost completely blocked the fist Oct4 elevation ( Figure 11B, top) , supporting a role of RNA PolII in this process. In addition, and unexpectedly, the second wave of Oct4 induction was also dramatically impaired ( Figure 11B , top). Again, these changes paralleled Oct4 transcript levels: the first up-regulation of Oct4 mRNA was inhibited, the second rise in Oct4 transcription was also severely compromised, albeit not fully blocked, such that Oct4 transcripts were up-regulated five-to sevenfold above the 48-h baseline instead of the ϳ25-fold normally observed ( Figure 11D ). This suggests that the second, long-lasting induction of Oct4 up-regulation is dependent on an early, short-term boost of Oct4 transcription and/or translation.
DRB exposure from 36 to 60 h after extract treatment, during the dip in Oct4 mRNA and protein levels, did not affect early Oct4 transcript and protein levels and only slightly delayed the second rise of Oct4 ( Figure 11B , middle). This delay was also noticed at the transcript level, but it did not significantly affect Oct4 mRNA or protein level at 7 d (168 h; Figure 11D ). Moreover, DRB applied from 55 to 84 h after extract treatment completely abrogated Oct4 transcription and translation by 72 h, but removal of the drug ultimately restored control Oct4 levels ( Figure 11B , bottom, and D). Thus, there is a requirement for PolII activity for de novo transcription of Oct4 3 d after extract treatment. Last, both Oct4 elevations were abolished upon incubation with 10 g/ml CHX, a protein synthesis inhibitor ( Figure 11C ). We concluded that whereas uptake of limited amounts of short-lived extractderived Oct4 protein probably occurs, the two phases of Oct4 induction result from transcriptional and translational activity in extract-treated cells.
In summary, this study provides transcriptional and functional evidence that an extract of undifferentiated EC or ES cells can induce markers of dedifferentiation and signs of differentiation plasticity in an otherwise more developmentally restricted cell type. Furthermore, the NCCIT extract induces DNA demethylation of OCT4, indicative of an epigenetic reprogramming event at this locus.
DISCUSSION
Target Cell Type-specific Programming of Gene Expression
The induction of a transcriptional profile of, according to our data, uncertain stability, suggests the establishment of a program of gene expression, as opposed to a complete functional reprogramming such as that occurring after nuclear transfer. Of the hundreds of NCCIT-specific genes up-or down-regulated on any given week after NCCIT extract treatment, only 5-7% are altered by Jurkat extract, and most of these genes overlap with genes altered (statistically by chance) in cells exposed to their own extract. This argues for some cell-type specificity in the nature of genes modulated by extract treatment. Despite some stability in the expression profile of specific genes after extract exposure, not all changes seem to be heritable. Genes with unstable expression pattern may include "passive bystanders" that generate a transcriptional noise (Paulsson, 2004) and result from more specific alterations in the transcriptional network. Perturbation in the network, however, would be expected to lead to changes trickling down the network until a transcriptional equilibrium is reached (Miklos and Maleszka, 2004) . Fluctuations in the gene expression profile therefore may result from incomplete reprogramming and from heterogeneity in the transcriptional response to extract treatment. Nevertheless, the dynamics of gene expression may also illustrate a temporal compartmentalization, in terms of timing, duration, and periodicity of gene activity required to establish a heritable transcriptional network (Klevecz et al., 2004) . 
